OrbiMed’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $21.3M | Hold |
|
|||||
|
2023
Q4 | $19M | Hold |
|
|||||
|
2023
Q3 | $11.2M | Hold |
|
|||||
|
2023
Q2 | $24.3M | Buy |
|
|||||
|
2023
Q1 | $32.1M | Buy |
|
|||||
|
2022
Q4 | $24.7M | Hold |
|
|||||
|
2022
Q3 | $48.3K | Hold |
|
|||||
|
2022
Q2 | $51K | Hold |
|
|||||
|
2022
Q1 | $45.5M | Buy |
|
|||||
|
2021
Q4 | $68.2M | Hold |
|
|||||
|
2021
Q3 | $88.6M | Hold |
|
|||||
|
2021
Q2 | $89.6M | Hold |
|
|||||
|
2021
Q1 | $120M | Hold |
|
|||||
|
2020
Q4 | $153M | Buy |
|